Mankind Pharma Limited has informed the Exchange regarding a press release dated February 03, 2026, titled "Financial Results Q3FY26".
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma Limited has informed the stock exchange about a press release dated February 3, 2026, sharing its financial results for the third quarter of FY26 (Q3FY26). The filing itself is only an intimation of the press release, and the detailed numbers are contained in the linked press release document. Investors will need to review the full press release for specific metrics such as revenue, profit after tax, EBITDA, and segment performance. This is a routine regulatory disclosure required after a company finalises its quarterly earnings.
No immediate price impact from this intimation itself, but the underlying Q3FY26 numbers could move the stock depending on whether results beat or miss market expectations. Shareholders should review the detailed press release for actual financial performance.